U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H19N3O3S.C6H12O7
Molecular Weight 589.614
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AMSACRINE GLUCONATE

SMILES

OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.COC1=C(NC2=C3C=CC=CC3=NC4=C2C=CC=C4)C=CC(NS(C)(=O)=O)=C1

InChI

InChIKey=XXNAQBNJPZNRSZ-IFWQJVLJSA-N
InChI=1S/C21H19N3O3S.C6H12O7/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21;7-1-2(8)3(9)4(10)5(11)6(12)13/h3-13,24H,1-2H3,(H,22,23);2-5,7-11H,1H2,(H,12,13)/t;2-,3-,4+,5-/m.1/s1

HIDE SMILES / InChI

Molecular Formula C6H12O7
Molecular Weight 196.1553
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula C21H19N3O3S
Molecular Weight 393.459
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: https://www.ncbi.nlm.nih.gov/pubmed/3884748 | https://www.ncbi.nlm.nih.gov/pubmed/2752503

The gluconate formulation of amsacrine (AMSA) has better water solubility then DMA formulation. It was thus developed and investigated to determine if it would be less cardiotoxic than the widely used N,N-dimethylacetamide (DMA) formulation. Amsacrine gluconate is the anticancer agent, which was tested against refractory leukemia. Moreover, their cytotoxic activity was demonstrated in the in vitro studies on 48 specimens of 9 histologically different types of human malignancy. The use of the gluconate formulation of AMSA, which contains no dimethylacetamide, has been associated with three cases of cardiomyopathy. Also, paresthesia was found in one patient among 26 treated with AMSA gluconate. This preparation has no apparent advantage when compared with amsacrine lactate.

Originator

Curator's Comment: Amsacrine preparation

Approval Year

PubMed

PubMed

TitleDatePubMed
Patents

Patents

Sample Use Guides

120 mg/m2 daily for 5 days
Route of Administration: Intravenous
In Vitro Use Guide
A total of 128 human tumors were placed in culture and tested against amsacrine. At 10 ug/ml amsacrine gluconate showed cytotoxic activity against breast, colon, and lung cancer as well as melanoma with an overall activity of 37%.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:32:02 GMT 2023
Edited
by admin
on Fri Dec 15 15:32:02 GMT 2023
Record UNII
M4P91439UZ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AMSACRINE GLUCONATE
Common Name English
METHANESULFONAMIDE, N-(4-(9-ACRIDINYLAMINO)-3-METHOXYPHENYL)-, MONO-D-GLUCONATE
Common Name English
NSC-334213
Code English
D-GLUCONIC ACID, COMPD. WITH N-(4-(9-ACRIDINYLAMINO)-3-METHOXYPHENYL)METHANESULFONAMIDE (1:1)
Common Name English
Code System Code Type Description
PUBCHEM
22824017
Created by admin on Fri Dec 15 15:32:02 GMT 2023 , Edited by admin on Fri Dec 15 15:32:02 GMT 2023
PRIMARY
CAS
80277-07-2
Created by admin on Fri Dec 15 15:32:02 GMT 2023 , Edited by admin on Fri Dec 15 15:32:02 GMT 2023
PRIMARY
NSC
334213
Created by admin on Fri Dec 15 15:32:02 GMT 2023 , Edited by admin on Fri Dec 15 15:32:02 GMT 2023
PRIMARY
FDA UNII
M4P91439UZ
Created by admin on Fri Dec 15 15:32:02 GMT 2023 , Edited by admin on Fri Dec 15 15:32:02 GMT 2023
PRIMARY
EPA CompTox
DTXSID001001136
Created by admin on Fri Dec 15 15:32:02 GMT 2023 , Edited by admin on Fri Dec 15 15:32:02 GMT 2023
PRIMARY
DRUG BANK
DBSALT002301
Created by admin on Fri Dec 15 15:32:02 GMT 2023 , Edited by admin on Fri Dec 15 15:32:02 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE